CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-24 | Chi Michael Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −2,100 | 192,942 | ||
| 2025-07-23 | Chi Michael Chief Commercial Officer | Exercise or conversion 10b5-1 | +12,600 | $5.01 | $63K | 291,254 |
| 2025-07-23 | Chi Michael Chief Commercial Officer | Exercise or conversion 10b5-1 | +900 | $6.82 | $6K | 292,154 |
| 2025-07-23 | Chi Michael Chief Commercial Officer | Exercise or conversion 10b5-1 | +250 | $11.53 | $3K | 292,404 |
| 2025-07-23 | Chi Michael Chief Commercial Officer | Sale 10b5-1 | −13,750 | $56.00 | $770K | 278,654 |
| 2025-07-23 | Chi Michael Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −12,600 | 195,042 | ||
| 2025-07-23 | Chi Michael Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −900 | 124,362 | ||
| 2025-07-23 | Chi Michael Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −250 | 49,606 | ||
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +17,001 | $2.43 | $41K | 109,314 |
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −17,001 | $49.43 | $840K | 92,313 |
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +16,667 | $2.43 | $41K | 108,980 |
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −16,667 | $49.41 | $824K | 92,313 |
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +41,667 | $2.43 | $101K | 133,980 |
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −41,667 | $49.56 | $2.1M | 92,313 |
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +50,000 | $2.43 | $122K | 142,313 |
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −50,000 | $49.60 | $2.5M | 92,313 |
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −17,001 | 68,008 | ||
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −16,667 | 848,064 | ||
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −41,667 | 806,397 | ||
| 2025-07-21 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −50,000 | 756,397 |
Page 28 of 37 · 739 trades